The conversion from 13D to 13G removes near-term activist pressure, but Tang Capital retains a 6% stake. Monitor for any future 13D re-filing or changes in stake size, which would signal renewed activist intent.
Price Chart
Executive Summary
Tang Capital Management, led by Kevin Tang, filed a Schedule 13G converting its prior Schedule 13D status for Atea Pharmaceuticals, certifying it no longer holds shares with the purpose of influencing control. The group beneficially owns 4,814,700 shares (6.0% of outstanding common stock) as of the filing date. This passive filing signals a de-escalation from activist intent, though the stake remains sizable.
Key Financial Metrics
Key Facts
- Tang Capital Management and affiliated entities filed a Schedule 13G, converting from a prior Schedule 13D filed May 22, 2023.
- The group beneficially owns 4,814,700 shares of Atea common stock, representing 6.0% of shares outstanding.
- The filing certifies the securities were not acquired and are not held with the purpose or effect of changing or influencing control of the issuer.
- Kevin Tang is the manager of Tang Capital Management and CEO of Tang Capital Partners III and IV.
- The percentage is based on 80,204,699 shares outstanding as of August 10, 2026, per the issuer's Form 10-Q.
Financial Impact
Passive stake of 6.0% — no financial impact from the filing itself.
Risk Factors
- Tang Capital could re-convert to 13D if it resumes activist activities.
- A 6% passive stake still allows for significant influence if the group chooses to engage privately.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0001214659-26-012604 |
| Document: 0001214659-26-012604-index-headers.html | 0001214659-26-012604 |
| Document: 0001214659-26-012604-index.html | 0001214659-26-012604 |
| Document: 0001214659-26-012604.txt | 0001214659-26-012604 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 6, 2026 20d ago | SC 13G | $5.01 | awaiting T+60 | — | $4.16 (−16.97%) |
Jul 14, 2026 14w ago | Press Release | $4.70 $5.01 | ▲ +6.60% | ▲ +3.22% | $4.16 (−11.49%) |
May 12, 2026 23w ago | Press Release | $4.57 $5.25 | ▼ −14.88% | ▼ −10.44% | $4.16 (+8.97%) |
Apr 27, 2026 26w ago | DEFA14A | $5.58 $4.75 | ▼ −14.87% | ▼ −18.86% | $4.16 (−25.45%) |
Mar 5, 2026 33w ago | 8-K | $5.89 $4.38 | ▼ −25.64% | ▼ −38.42% | $4.16 (−29.37%) |
Mar 5, 2026 33w ago | Press Release | $5.89 $4.38 | ▼ −25.64% | ▼ −38.42% | $4.16 (−29.37%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers